Related Experiment Video
Updated: Dec 7, 2025

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
Published on: August 11, 2023
Clinical Characteristics of Stroke with COVID-19: A Systematic Review and Meta-Analysis
Mai Yamakawa1, Toshiki Kuno2, Takahisa Mikami3
1Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
Insights
COVID-19 patients had a 1.1% stroke frequency, often in older individuals with risk factors. This highlights a significant thromboembolism risk and high mortality in COVID-19 patients with stroke.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) is linked to increased risks of thromboembolism and stroke.
- Existing studies on COVID-19 patients with stroke show varied characteristics regarding demographics, comorbidities, treatments, and outcomes.
Purpose of the Study:
- To determine the frequency and clinical characteristics of stroke in patients diagnosed with COVID-19.
- To synthesize existing evidence on the association between COVID-19 and stroke.
Main Methods:
- A systematic review and meta-analysis were conducted using data from PubMed and EMBASE up to June 10, 2020.
- Included studies comprised retrospective cross-sectional studies, case series, and case reports, adhering to PRISMA guidelines.
- One-group meta-analysis with a random-effects model was used to combine study-specific estimates.
Main Results:
- 183 patients with COVID-19 and stroke were identified across 10 cohort studies and 16 case series/reports.
- The frequency of stroke in hospitalized COVID-19 patients was 1.1% (95% CI: 0.6-1.6%).
- The mean age of affected patients was 66.6 years, with 65.6% being male. Cryptogenic stroke was common (50.7%), and the case fatality rate was 44.2%.
Conclusions:
- Stroke occurred in 1.1% of hospitalized COVID-19 patients, predominantly in older individuals with pre-existing stroke risk factors.
- Elevated D-dimer levels and a high incidence of cryptogenic stroke suggest an increased risk of thromboembolism in COVID-19.
- Further research is crucial to understand the pathophysiology and prognosis of stroke in COVID-19 to optimize patient care.
Background:
The coronavirus disease 2019 (COVID-19) potentially increases the risk of thromboembolism and stroke. Numerous case reports and retrospective cohort studies have been published with mixed characteristics of COVID-19 patients with stroke regarding age, comorbidities, treatment, and outcome. We aimed to depict the frequency and clinical characteristics of COVID-19 patients with stroke.
Methods:
PubMed and EMBASE were searched on June 10, 2020, to investigate COVID-19 and stroke through retrospective cross-sectional studies, case series/reports according to PRISMA guidelines. Study-specific estimates were combined using one-group meta-analysis in a random-effects model.
Results:
10 retrospective cohort studies and 16 case series/reports were identified including 183 patients with COVID-19 and stroke. The frequency of detected stroke in hospitalized COVID-19 patients was 1.1% ([95% confidential interval (CI)]: [0.6-1.6], I2 = 62.9%). Mean age was 66.6 ([58.4-74.9], I2 = 95.1%), 65.6% was male (61/93 patients). Mean days from symptom onset of COVID-19 to stroke was 8.0 ([4.1-11.9], p< 0.001, I2 = 93.1%). D-dimer was 3.3 μg/mL ([1.7-4.9], I2 = 86.3%), and cryptogenic stroke was most common as etiology at 50.7% ([31.0-70.4] I2 = 64.1%, 39/71patients). Case fatality rate was 44.2% ([27.9-60.5], I2 = 66.7%, 40/100 patients).
Conclusions:
This systematic review assessed the frequency and clinical characteristics of stroke in COVID-19 patients. The frequency of detected stroke in hospitalized COVID-19 patients was 1.1% and associated with older age and stroke risk factors. Frequent cryptogenic stroke and elevated d-dimer level support increased risk of thromboembolism in COVID-19 associated with high mortality. Further study is needed to elucidate the pathophysiology and prognosis of stroke in COVID-19 to achieve most effective care for this population.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies

